Author: OurCrowd

[Polarisqb in Quantum Computing Report] Polaris Quantum Biotech study demonstrates quantum advantage over generative AI in drug discovery

Jan 12, 2026 |

Polaris Quantum Biotech (PolarisQB) has released a comparative study indicating that its Quantum-Aided Drug Design (QuADD) platform, powered by D-Wave Quantum Inc.’s annealing technology, significantly outperforms classical Generative AI in lead identification for drug discovery. The study, currently a preprint on ChemRxiv, compared QuADD to the Bond and Interaction generating Diffusion model (BInD), a representative AI-based diffusion algorithm. The findings suggest that quantum annealing can reduce the timeline for selecting pre-clinical molecular candidates from months to hours while delivering higher-quality results. Watch...

Read More

[MeMed in MeMed] MeMed awarded $2 million grant to establish a first-of-Its-kind acute care digital and physical biobank

Jan 12, 2026 |

HAIFA, Israel, Jan. 12, 2026 /PRNewswire/ — MeMed, the leader in host-response diagnostics, announced it has been awarded a competitive national grant through the IIA to establish an acute-care diagnostics and proteomics biobank, as part of a nationwide AI R&D data infrastructure. This initiative significantly accelerates the development and validation of next-generation AIVD™ (Artificial Intelligence In Vitro Diagnostics) for high-risk patients by combining acute-care biospecimens with linked clinical data and high-resolution immune profiling. Read more...

Read More